151 related articles for article (PubMed ID: 36675023)
1. New Transcriptomic Biomarkers of 5-Fluorouracil Resistance.
Fekete JT; Győrffy B
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675023
[TBL] [Abstract][Full Text] [Related]
2. APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.
Petty RD; Samuel LM; Murray GI; MacDonald G; O'Kelly T; Loudon M; Binnie N; Aly E; McKinlay A; Wang W; Gilbert F; Semple S; Collie-Duguid ES
BMC Cancer; 2009 Dec; 9():434. PubMed ID: 20003335
[TBL] [Abstract][Full Text] [Related]
3. Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy.
Phua LC; Mal M; Koh PK; Cheah PY; Chan EC; Ho HK
Cancer Chemother Pharmacol; 2013 Mar; 71(3):817-23. PubMed ID: 23271323
[TBL] [Abstract][Full Text] [Related]
4. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer.
Zhao Y; Wang C; Goel A
Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896
[TBL] [Abstract][Full Text] [Related]
5. Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients.
Fekete JT; Ősz Á; Pete I; Nagy GR; Vereczkey I; Győrffy B
Gynecol Oncol; 2020 Mar; 156(3):654-661. PubMed ID: 31973910
[TBL] [Abstract][Full Text] [Related]
6. Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancer.
Tan WL; Bhattacharya B; Loh M; Balasubramanian I; Akram M; Dong D; Wong L; Thakkar B; Salto-Tellez M; Soo RA; Fichtner I; Iacopetta B; Soong R
Cancer Biol Ther; 2011 Mar; 11(6):599-608. PubMed ID: 21378502
[TBL] [Abstract][Full Text] [Related]
7. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
8. METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma.
Li M; Xia M; Zhang Z; Tan Y; Li E; Guo Z; Fang M; Zhu Y; Hu Z
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35856434
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer.
Abdalla AN; Malki WH; Qattan A; Shahid I; Hossain MA; Ahmed M
Molecules; 2021 Jan; 26(2):. PubMed ID: 33440689
[TBL] [Abstract][Full Text] [Related]
10. ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway.
Wang Z; Zhao X; Wang W; Liu Y; Li Y; Gao J; Wang C; Zhou M; Liu R; Xu G; Zhou Q
Int J Oncol; 2018 Nov; 53(5):2102-2110. PubMed ID: 30106136
[TBL] [Abstract][Full Text] [Related]
11. Targeting PTGES/PGE2 axis enhances sensitivity of colorectal cancer cells to 5-fluorouracil.
Geng S; Zhan H; Cao L; Geng L; Ren X
Biochem Cell Biol; 2023 Dec; 101(6):501-512. PubMed ID: 37358009
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells.
Fan H; Zhu JH; Yao XQ
Mol Med Rep; 2018 Jun; 17(6):8309-8315. PubMed ID: 29693171
[TBL] [Abstract][Full Text] [Related]
13. Role of genomic factors beyond thymidylate synthase in the prediction of response to 5-fluorouracil.
Peters GJ; Smid K; Meijer E; van Groeningen CJ; Leon LG
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):595-603. PubMed ID: 27906628
[TBL] [Abstract][Full Text] [Related]
14. Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells.
Sousa-Squiavinato ACM; Arregui Ramos DA; Wagner MS; Tessmann JW; de-Freitas-Junior JCM; Morgado-Díaz JA
Eur J Pharmacol; 2022 Oct; 933():175253. PubMed ID: 36067803
[TBL] [Abstract][Full Text] [Related]
15. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
16. Casein Kinase 2α Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
Kim HJ; Han YS; Lee JH; Lee SH
Anticancer Res; 2020 Mar; 40(3):1419-1426. PubMed ID: 32132038
[TBL] [Abstract][Full Text] [Related]
17. Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer.
McCann C; Matveeva A; McAllister K; Van Schaeybroeck S; Sessler T; Fichtner M; Carberry S; Rehm M; Prehn JHM; Longley DB
FEBS J; 2021 Sep; 288(18):5374-5388. PubMed ID: 33660894
[TBL] [Abstract][Full Text] [Related]
18. The Novel 5-Fluorouracil Loaded Ruthenium-based Nanocarriers Enhanced Anticancer and Apoptotic Efficiency while Reducing Multidrug Resistance in Colorectal Cancer Cells.
Danişman-Kalindemirtaş F; Özerkan D; Kariper İA; Bulut H
J Fluoresc; 2023 May; 33(3):1227-1236. PubMed ID: 36811696
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo studies on the association of long non‑coding RNAs H19 and urothelial cancer associated 1 with the susceptibility to 5‑fluorouracil in rectal cancer.
Yokoyama Y; Sakatani T; Wada R; Ishino K; Kudo M; Koizumi M; Yamada T; Yoshida H; Naito Z
Int J Oncol; 2019 Dec; 55(6):1361-1371. PubMed ID: 31638183
[TBL] [Abstract][Full Text] [Related]
20. HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy.
Nagaraju GP; Alese OB; Landry J; Diaz R; El-Rayes BF
Oncotarget; 2014 Oct; 5(20):9980-91. PubMed ID: 25296971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
